BAY CITY CAPITAL
Bay City Capital LLC (Bay City Capital) was established in 1997 for the purpose of managing investment funds in the life sciences industry. Since that date, they have managed six venture funds representing $1.5 billion in capital invested in over 70 companies. Five of these funds are general life sciences funds, and one is a nutrition and agribusiness sector fund.
BAY CITY CAPITAL
Industry:
Biotechnology
Founded:
1997-01-01
Status:
Active
Contact:
415.676.3830
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics WordPress Google Universal Analytics Nginx Sitelinks Search Box Microsoft Exchange Online IPv6
Similar Organizations
Clarus Ventures
Clarus Ventures is a Massachusetts-based venture capital firm focused on investments in the healthcare sector.
Reaction Biology
Reaction Biology is an industry leader and innovator specializing in assay services and protein production for early-stage drug discovery
Current Advisors List
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-05-04 | Oculis | Bay City Capital investment in Series C - Oculis | 57 M USD |
2020-11-13 | Bridge Medicines | Bay City Capital investment in Venture Round - Bridge Medicines | 10 M USD |
2020-10-01 | Sembiosys Genetics | Bay City Capital investment in Venture Round - Sembiosys Genetics | N/A |
2020-03-02 | Xilio Therapeutics | Bay City Capital investment in Series B - Xilio Therapeutics | 100.5 M USD |
2019-03-18 | Imara | Bay City Capital investment in Series B - Imara | 63 M USD |
2018-11-13 | NextCure | Bay City Capital investment in Series B - NextCure | 93 M USD |
2018-07-23 | Gossamer Bio | Bay City Capital investment in Series B - Gossamer Bio | 230 M USD |
2018-01-05 | KBP Biosciences | Bay City Capital investment in Series A - KBP Biosciences | 76 M USD |
2018-01-04 | Oculis | Bay City Capital investment in Series B - Oculis | 20 M CHF |
2017-10-01 | Gritstone Bio | Bay City Capital investment in Venture Round - Gritstone Bio | N/A |